Patrizia Borsotti

Via Stezzano 87
Bergamo, 24126, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation.

Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation.

Journal: Pharmacological research
Published: January 19, 2026

The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization.

The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization.

Journal: Cell death & disease
Published: July 30, 2025

TSP-1 interaction with RANK and OPG: implications for bone remodeling and osteolytic bone metastasis.

TSP-1 interaction with RANK and OPG: implications for bone remodeling and osteolytic bone metastasis.

Journal: Cell death & disease
Published: May 20, 2025

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2024

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2023

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity.

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity.

Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: May 14, 2021

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.

Journal: Cells
Published: February 06, 2020

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Journal: Carcinogenesis
Published: June 28, 2018

The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).

The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).

Journal: Angiogenesis
Published: May 31, 2018

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Journal: Connective tissue research
Published: May 07, 2015

Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.

Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.

Journal: International journal of cancer
Published: November 15, 2013

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Journal: Pigment cell & melanoma research
Published: June 11, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026